← All trials
NCT03993236
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 22, 2019
- Primary completion
- Nov 12, 2020
- Completion date
- Nov 12, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 584
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Inje UniversityLead sponsor
- Korea UniversityCollaborator
- Kyung Hee UniversityCollaborator
- Seoul National UniversityCollaborator
- Yonsei UniversityCollaborator
- Hallym UniversityCollaborator
- Chung-Ang UniversityCollaborator
- Sungkyunkwan UniversityCollaborator
- Catholic University of KoreaCollaborator
- Seonam UniversityCollaborator
- Inje UniversitySponsor investigator
- Ewha Womans UniversityCollaborator
- Inje UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.